FDA Inspection
Megafine Pharma (P) LimitedMegafine Pharma (P) Limited – FDA Inspection, Jun 15, 2018
Record Details
This FDA Inspection record concerns Megafine Pharma (P) Limited, with an inspection on June 15, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5f17d11f-808d-4615-843d-37ed847ce74a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1058583
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Megafine Pharma (P) Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 12, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Megafine Pharma (P) Limited
- FDA Inspection 1207908 - 2023-05-12
- FDA Inspection 1121027 - 2020-02-21
- FDA Inspection 988000 - 2016-09-23
- FDA Inspection 828506 - 2013-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.